Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effects of Bisphosphonates on OI-Related Hearing Loss — Stella

Home/Osteogenesis Imperfecta/Effects of Bisphosphonates on OI-Related Hearing Loss

View on ClinicalTrials.gov

Recruiting

Back to Osteogenesis Imperfecta trials

Effects of Bisphosphonates on OI-Related Hearing Loss

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Hospital for Special Surgery, New York, New York

Key details

Phase

Post-approval study

Sponsor

Hospital for Special Surgery, New York

Collaborators

The New York Community Trust, East River Medical Imaging

Enrollment target

~100 participants

Started

November 2019

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

6 Years – 100 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.